Inventor
TOMAI MARK A
US15 patents
⚠️ This page may combine multiple inventors who share the name “TOMAI MARK A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
3M INNOVATIVE PROPERTIES CO
13 patentsUS6376669B1Apr 23, 2002
Dye labeled imidazoquinoline compounds
3M INNOVATIVE PROPERTIES CO378 citations99
US6916925B1Jul 12, 2005
Dye labeled imidazoquinoline compounds
3M INNOVATIVE PROPERTIES CO67 citations98
US6200592B1Mar 13, 2001
Immine response modifier compounds for treatment of TH2 mediated and related diseases
3M INNOVATIVE PROPERTIES CO274 citations98
US6039969AMar 21, 2000
Immune response modifier compounds for treatment of TH2 mediated and related diseases
3M INNOVATIVE PROPERTIES CO516 citations98
US7226928B2Jun 5, 2007
Methods for the treatment of periodontal disease
3M INNOVATIVE PROPERTIES CO69 citations97
US6696076B2Feb 24, 2004
Immune response modifier compounds for treatment of TH2 mediated and related diseases
3M INNOVATIVE PROPERTIES CO171 citations97
US6610319B2Aug 26, 2003
Immune response modifier compounds for treatment of TH2 mediated and related diseases
3M INNOVATIVE PROPERTIES CO111 citations97
US6558951B1May 6, 2003
Maturation of dendritic cells with immune response modifying compounds
3M INNOVATIVE PROPERTIES CO342 citations97
US6630588B2Oct 7, 2003
Dye labeled imidazoquinoline compounds
3M INNOVATIVE PROPERTIES CO66 citations96
US6365166B2Apr 2, 2002
Gel formulations for topical drug delivery
3M INNOVATIVE PROPERTIES CO130 citations96
US6083505AJul 4, 2000
1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants
3M INNOVATIVE PROPERTIES CO417 citations96
US5939090AAug 17, 1999
Gel formulations for topical drug delivery
3M INNOVATIVE PROPERTIES CO379 citations96
US9801947B2Oct 31, 2017
Methods and compositions for enhancing immune response
3M INNOVATIVE PROPERTIES CO7 citations81